Arrhythmias and women

Current Opinion in Cardiology

Volumn 14, Issue 1, 1999, Pages 36-43

  Wolbrette, Deborah ^a   Patel, Hemantkumar ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; HALOFANTRINE; PROBUCOL; SOTALOL; TERFENADINE;

ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HUMAN; LONG QT SYNDROME; MALE; PREGNANCY; PRIORITY JOURNAL; QT INTERVAL; REENTRY TACHYCARDIA; REVIEW; RISK FACTOR; SEX RATIO; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; TORSADE DES POINTES;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ATRIAL FIBRILLATION; DEATH, SUDDEN, CARDIAC; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; INCIDENCE; LONG QT SYNDROME; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; SEX CHARACTERISTICS; SEX FACTORS; TACHYCARDIA, SUPRAVENTRICULAR; TORSADES DE POINTES;

EID: 0032984698     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199901000-00007     Document Type: Review

References (49)

1. 1 Bazett H: An analysis of the time relations of electrocardiograms. Heart 1920, 7:353-370.
2. 2 Ashman R: The normal duration of the QT interval. Am Heart J 1942, 23:522-534.
3. 3 Jose A, Collison D: The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res 1970, 4:160-167.
4. 4 Larsen JA, Kadish AH: Effects of gender on cardiac arrhythmias. J Cardiovasc Electrophysiol 1998, 9:655-664. An excellent review of the gender effects on arrhythmias with an emphasis on basic electrophysiologic findings.
5. 5 Burke J, Goldberger J, Ehlert FA, Kruse JT, Parker MA, Kadish AH: Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med 1996, 100:537-543.
6. 6 Molnar J, Zhang F, Weiss J, Ehlert FA, Rosenthal JE: Diurnal pattern of QTc interval: how long is it prolonged? Possible relation to circadian triggers of cardiovascular events. J Am Coll Cardiol 1996, 27:76-83.
7. 7 Rautaharju P, Zhou S, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A: Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992, 8:690-695.
8. 8 Kligfield P, Lax K, Okin P: QT interval heart rate relation during exercise in normal men and women: Definition by linear regression analysis. J Am Coll Cardiol 1996, 28:1547-1555.
9. 9 Stramba-Badiale M, Locati E, Martinelli A, Courville J, Swartz PJ: Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-hour Holter monitor recordings. Eur Heart J 1997, 18:1000-1006.
10. 10 Merri M, Benhorin J, Alberti M, Locati E, Moss AJ: Electrocardiographic quantitation of ventricular repolarization. Circulation 1989, 80:1301-1308.
11. 11 Yang H, Elko P, LeCarpenter GL, et al.: Sex differences in the rate of cardiac repolarization. J Electrocardiol 1997, 30:267-276.
12. 12 Kadish AH : The effect of gender on cardiac electrophysiology and arrhythmias. In Cardiac Electrophysiology: From Cell to Bedside, Second Edition. Edited by Zipes DP, Jalife J. Philadelphia: WB Saunders; 1995:1268-1275.
13. 13 Volkmann H, Schnerch B, Kuhnert H: Diagnostic value of carotid sinus hypersensitivity. Pacing Clin Electrophysiol 1990, 13:2065-2070.
14. 14 Rodriquez LM, deChillou C, Schlapfer J, Metzger J, Baiyan X, van den Dool A, et al.: Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol 1992, 70:1213-1215.
15. 15 Jackman WM, Beckman KJ, McClelland JH, Wang X, Friday KJ, Roman CA, et al.: Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow pathway conduction. N Engl J Med 1992, 327:313-318.
16. 16 Calkins H, Langberg J. Sousa J, el-Atassi R, Leon A, Kou W, et al.: Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Circulation 1992, 85:1337-1346.
17. 17 Swartz J, Tracy C, Fletcher R: Radiofrequency end catheter ablation of accessory atrioventricular pathway atrial insertion sites. Circulation 1993, 87:487-499.
18. 18 Benjamen EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA: Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 1994, 271:840-844.
19. 19 Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS: Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol 1998, 61:714-717.
20. 20 Feinberg WM, Blackshear JL, Laupacis A, Kronmol R, Hart RG: Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 1995, 155:469-473.
21. 21 Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D: Impact of atrial fibrillation on the risk of death, the Framingham Heart Study. Circulation 1998, 98:946-952. This analysis of the Framingham Heart Study cohort provides important data regarding gender differences in the risk factors for atrial fibrillation.
22. 22 Cooklin M, Gold MR: Implications and treatment of atrial fibrillation after cardiothoracic surgery. Curr Opin Cardiol 1998, 13:20-28.
23. 23 Cabin HS, Clubb S, Hall C, Perlmutter RA, Feinstein AR: Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol 1990, 65:1112-1116.
24. 24 Suttorp MJ, Kingma H, Koomen EM, Hof AV, Tijssen JE, Lie KI: Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 1993, 71:710-713.
25. 25 Rubart M, Von der Lohe E: Sex steroids and cardiac arrhythmia: more questions than answers. J Cardiovasc Electrophysiol 1998, 9:665-667.
26. 26 Kannel WB, Wilson PWF, D'Agostino RB, Cobb J: Sudden coronary death in women. Am Heart J 1998, 136:205-212. A prospective examination of the Framingham cohort, looking at the incidence and risk factors for SCD in women compared with men.
27. 27 Beard CM, Griffin MR, Offord KP, Edwards WD: Risk factors for sudden unexpected cardiac death in young women in Rochester, Minnesota, 1960 through 1974. Mayo Clin Proc 1986, 61:186-191.
28. 28 Talbott EO, Kuller LH, Detre K, Matthews K, Norman S, Kelsey SF, Belle S: Reproductive history of women dying of sudden cardiac death: a case-control study. Int J Epidemiol 1989, 18:589-594.
29. 29 Olsson G, Wikstrand J, Warnold I, Manger Cats V, McBoyle D, Herlitz J, et al.: Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J 1992, 13:28-32.
30. 30 Kudenchuk PJ, Bardy GH, Poole JE, Dolock GL, Gleva MJ, Reddy R, et al.: Malignant sustained ventricular tachyarrhythmias in women: characteristics and outcome of treatment with an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 1997, 8:2-10.
31. 31 Panotopoulos PT, Axtell K, Anderson AJ, Sra J, Blanck Z, Deshpande S, et al.: Efficacy of the implantable cardioverter-defibrillator in the elderly. J Am Coll Cardiol 1997, 29:556-560.
32. 32 Horton RP, Canby RC, Roman CA, Hull ML, Kaye SA, Jessen ME, Page RL: Determinants of nonthoracotomy biphasic defibrillation. Pacing Clin Electrophysiol 1997, 20(Part 1):60-64.
33. 33 Makkar R, Fromm B, Steinman R: Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993, 270:2590-2597.
34. 34 Pratt CM, Camm AJ, Cooper W, Friedman PL, MacNeil DJ, Moulton KM, et al.: Mortality in the survival with oral d-sotalol (SWORD) trial: why did patients die? Am J Cardiol 1998, 81:869-876. An in-depth interpretation of the SWORD trial, pointing out the significantly increased mortality risk of women taking oral d-sotalol.
35. 35 Kühlkamp V, Mermi J, Mewis C, Seipel L: Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias. J Cardiovasc Pharmacol 1997, 29:373-381.
36. 36 Karam R, Marcello S, Brooks RR, Corey AE, Moore A: Azimilide dihydrochloride, a novel antiarrhythmic agent. Am J Cardiol 1998, 81:40D-46D.
37. 37 Camm AJ, Karam R, Pratt CM: The Azimilide Postinfarct Survival Evaluation (ALIVE) Trial. Am J Cardiol 1998, 81:35D-39D.
38. 38 Reinoehl J, Frankovich D, Machado C, Kawasaki R, Baga JJ, Pires LA, et al.: Probucol-associated tachyarrhythmic events and QT prolongation: importance of gender. Am Heart J 1996, 131:1184.
39. 39 Drici MD, Knollmann B, Wang W-X, Woosley RL: Gender and reports of erythromycin-related arrhythmias. Circulation 1997, 96:1211.
40. 40 Woosley RL, Chen Y, Freiman JP, Gillis RA: Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993, 269:1532.
41. 41 Ebert SN, Liu X-K, Woosley RL: Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence. Journal of Women's Health 1998, 7:547-550. An excellent review of the literature and Food & Drug Administration's databases revealing women's increased risk of developing drug-induced TDP.
42. 42 Kawasaki R, Machado C, Reinoehl J: Increased propensity of women to develop torsado de pointes during complete heart block. J Cardiovasc Electrophysiol 1995, 6:1032-1038.
43. 43 Challapalli S, Lingamneni R, Horvath G, et al.: Twelve lead QT dispersion is lower in women. Ann Noninvasive Electrocardiol 1998, 3:25-31. QT dispersion is becoming an important area of active research, making this study recommended reading.
44. 44 Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, et al.: The long QT syndrome: prospective longitudinal study of 328 families. Circulation 1991, 84:1136.
45. 45 Lehmann MH, Timothy KW, Frankovich D, Fromm BS, Keating M, Locati EH, et al.: Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol 1997, 29:93-99.
46. 46 Rashba EJ, Zareba W, Moss AJ, Hall WJ, Robinson J, Locati EH, et al. for the LQTS Investigators: Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. Circulation 1998, 97:451-456. Investigators of the long QT syndrome discuss important data regarding the risk for cardiac events during and after pregnancy. Surprisingly, the postpartum interval is associated with the highest risk. The investigators recommend continuation of β-blocker therapy during pregnancy and postpartum in these women with long QT syndrome.
47. 47 Tawam M, Levine J, Mendelson M, Goldberger J, Dyer A, Kadish A: Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol 1993, 72:838-840.
48. 48 Widerhorn J, Wilderhorn A, Rahimtoola S, Elkayam U: WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias. Am Heart J 1992, 123:769-798.
49. 49 Brodsky M, Doria R, Allen B, Sato D, Thomas G, Sada M: New onset ventricular tachycardia during pregnancy. Am Heart J 1992, 123:933-941.